orbofiban has been researched along with adenosine diphosphate in 2 studies
| Studies (orbofiban) | Trials (orbofiban) | Recent Studies (post-2010) (orbofiban) | Studies (adenosine diphosphate) | Trials (adenosine diphosphate) | Recent Studies (post-2010) (adenosine diphosphate) |
|---|---|---|---|---|---|
| 48 | 17 | 0 | 23,989 | 498 | 3,114 |
| Protein | Taxonomy | orbofiban (IC50) | adenosine diphosphate (IC50) |
|---|---|---|---|
| Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | 0.45 | |
| Heat shock 70 kDa protein 1A | Homo sapiens (human) | 0.5 | |
| Sensor protein kinase WalK | Staphylococcus aureus | 7.189 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, F; Naganuma, H; Ogawa, T; Sugidachi, A | 1 |
| Feuerstein, GZ; Friedman, SM; Gibbs, SK; Racanelli, AL; Seiffert, DA; Zondlo, SC | 1 |
2 other study(ies) available for orbofiban and adenosine diphosphate
| Article | Year |
|---|---|
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea | 2000 |
Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro.
Topics: Adenosine Diphosphate; Alanine; Blood Platelets; Humans; In Vitro Techniques; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Time Factors | 2003 |